Atlas Trials

Innovative Diagnosis and Therapy in LDLT Patients With High-risk Hepatocellular Carcinoma

Clinical trial NCT06327269 · RECRUITING

Trial details

NCT number
NCT06327269
Sponsor
Chang Gung Memorial Hospital
Status
RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
High Risk of Recurrence
Start date
2021-04-01
Primary completion
2024-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.